Trial intelligence / Profile preview

Ezetimibe Plus Atorvastatin vs Atorvastatin Titration in High Risk Hypercholesterolemia

NCT00276484Phase 3Completed

Sponsor
Organon & Co.
Start
Feb 2006
Primary completion
Feb 2008
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Feb 2006; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00276484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00276484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call